Bendamustine in Acute Leukemia and MDS
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Busulfan Plus Cyclophosphamide vs Fludarabine as a Conditioning Regimen
- Status
- COMPLETED
- Phase
- PHASE3
High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML
- Status
- COMPLETED
- Phase
- PHASE2
Blood Samples to Evaluate Biomarkers of Donor Chimerism
- Status
- COMPLETED
- Phase
- N/A
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1
Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies.
- Status
- COMPLETED
- Phase
- PHASE2
The Role of Erythropoietin in Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- N/A
Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
5-Azacytidine Prior to Allogeneic Stem Cell Transplant in High Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
- Status
- UNKNOWN
- Phase
- PHASE2
A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2